FDAnews Announces -- Blockchain Systems in Pharmaceuticals: Transform Quality and Compliance Webinar July 30, 2020
FALLS CHURCH, Va., July 16, 2020 /PRNewswire-PRWeb/ -- Blockchain Systems in Pharmaceuticals Transform Quality and Compliance An FDAnews Webinar Thursday, July 30, 2020, 1:30-3:30 p.m. EDT https://www.fdanews.com/blockchainsystems
Blockchains are revolutionizing the pharmaceutical industry, simplifying existing processes for data integrity. These secure databases keep track of all transactions ? concept, pre-clinical testing, phase I, II, III trials, approvals, postmarket surveillance, drug supply chain ? in a single system.
To stay competitive, one needs to understand the core tenets of distributed systems, blockchains and cryptography. James Canterbury ? a partner in Ernst & Young's Risk Advisory practice where he works with the global blockchain team ? will lay the foundation to leverage these systems:
Highlights of where blockchains are currently being used in the pharmaceutical industry, including manufacturing and the supply chain
The core components of blockchain technology, including single-source data integrity
Public vs. private blockchains and the challenges, advantages and disadvantages of each
How to use a blockchain as a notarization system
The role of non-fungible tokens in product track and trace in the COVID-19 era and beyond
Put blockchain to work for teh company to streamline processes, improve quality, ensure compliance and simplify data integrity.
Interested in registering multiple sites? Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally to learn about our special multisite discount.
Webinar Details: Blockchain Systems in Pharmaceuticals Transform Quality and Compliance An FDAnews Webinar Thursday, July 30, 2020, 1:30-3:30 p.m. EDT https://www.fdanews.com/blockchainsystems
About FDAnews: FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations
The "Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, GI etc.) by Place, by Product and by Country. With Market Analysis and Executive Guides. 2024 to 2028" report has been added to...
The "Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive Guides, Customized Forecasting and Analysis. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering....
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...